CUMBERLAND PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cumberland Pharmaceuticals Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Cumberland Pharmaceuticals Inc Entity Common Stock, Shares Outstanding for the quarter ending November 4, 2024 was 14M shares, a 1.5% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 14M -213K -1.5% Nov 4, 2024 10-Q 2024-11-08
Q2 2024 14.1M -276K -1.92% Aug 6, 2024 10-Q 2024-08-09
Q1 2024 14.2M -219K -1.52% Mar 8, 2024 10-K 2024-03-13
Q3 2023 14.3M -208K -1.44% Nov 7, 2023 10-Q 2023-11-13
Q2 2023 14.4M -291K -1.98% Aug 7, 2023 10-Q 2023-08-11
Q1 2023 14.4M -445K -3% Mar 7, 2023 10-K 2023-03-13
Q3 2022 14.5M -346K -2.33% Nov 7, 2022 10-Q 2022-11-14
Q2 2022 14.7M -218K -1.46% Aug 8, 2022 10-Q 2022-08-12
Q1 2022 14.8M -80.3K -0.54% Mar 7, 2022 10-K 2022-03-11
Q3 2021 14.8M -227K -1.51% Nov 8, 2021 10-Q 2021-11-12
Q2 2021 14.9M -259K -1.71% Aug 9, 2021 10-Q 2021-08-13
Q1 2021 14.9M -261K -1.72% Mar 8, 2021 10-K 2021-03-12
Q3 2020 15M -147K -0.97% Nov 10, 2020 10-Q 2020-11-13
Q2 2020 15.1M -235K -1.53% Aug 10, 2020 10-Q 2020-08-14
Q1 2020 15.2M -266K -1.72% Mar 16, 2020 10-K 2020-03-20
Q3 2019 15.2M -344K -2.21% Nov 6, 2019 10-Q 2019-11-13
Q2 2019 15.4M -194K -1.25% Aug 9, 2019 10-Q 2019-08-14
Q1 2019 15.4M -205K -1.31% Mar 5, 2019 10-K 2019-03-12
Q3 2018 15.5M -221K -1.4% Nov 9, 2018 10-Q 2018-11-14
Q2 2018 15.6M -328K -2.07% Aug 9, 2018 10-Q 2018-08-14
Q1 2018 15.7M -361K -2.26% Mar 6, 2018 10-K 2018-03-09
Q3 2017 15.7M -432K -2.67% Nov 3, 2017 10-Q 2017-11-08
Q2 2017 15.9M -329K -2.03% Aug 7, 2017 10-Q 2017-08-09
Q1 2017 16M -294K -1.8% Mar 6, 2017 10-K 2017-03-13
Q3 2016 16.2M -272K -1.65% Nov 1, 2016 10-Q 2016-11-03
Q2 2016 16.2M -403K -2.42% Aug 3, 2016 10-Q 2016-08-05
Q1 2016 16.3M -661K -3.9% Mar 4, 2016 10-K 2016-03-14
Q3 2015 16.5M -905K -5.22% Nov 2, 2015 10-Q 2015-11-06
Q2 2015 16.6M -950K -5.4% Aug 3, 2015 10-Q 2015-08-07
Q1 2015 17M -910K -5.09% Mar 3, 2015 10-K 2015-03-09
Q3 2014 17.4M -748K -4.13% Nov 3, 2014 10-Q 2014-11-07
Q2 2014 17.6M -688K -3.77% Aug 4, 2014 10-Q 2014-08-08
Q1 2014 17.9M -567K -3.07% Mar 3, 2014 10-K 2014-03-11
Q3 2013 18.1M -1M -5.26% Oct 29, 2013 10-Q 2013-11-06
Q2 2013 18.3M -1.32M -6.76% Jul 29, 2013 10-Q 2013-08-09
Q1 2013 18.4M -1.32M -6.69% Apr 29, 2013 10-Q 2013-05-08
Q3 2012 19.1M -1.07M -5.29% Oct 27, 2012 10-Q 2012-11-02
Q2 2012 19.6M -793K -3.89% Jul 27, 2012 10-Q 2012-08-09
Q1 2012 19.8M Apr 27, 2012 10-Q 2012-05-04
Q3 2011 20.2M Oct 28, 2011 10-Q 2011-11-07
Q2 2011 20.4M Jul 29, 2011 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.